SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,885,000 | +9.7% | 425,527 | +15.7% | 0.00% | 0.0% |
| Q3 2016 | $1,718,000 | -13.3% | 367,905 | +22.0% | 0.00% | -33.3% |
| Q2 2016 | $1,981,000 | +9.7% | 301,576 | +6.2% | 0.00% | +50.0% |
| Q1 2016 | $1,806,000 | +6.9% | 284,009 | +1.4% | 0.00% | 0.0% |
| Q4 2015 | $1,690,000 | +1.3% | 280,200 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $1,668,000 | -13.0% | 278,979 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $1,918,000 | +29.5% | 280,360 | +14.9% | 0.00% | 0.0% |
| Q1 2015 | $1,481,000 | -11.8% | 244,063 | +0.7% | 0.00% | 0.0% |
| Q4 2014 | $1,680,000 | -15.7% | 242,459 | -1.0% | 0.00% | -33.3% |
| Q3 2014 | $1,994,000 | +2.5% | 244,930 | +2.4% | 0.00% | 0.0% |
| Q2 2014 | $1,945,000 | +0.7% | 239,187 | -2.9% | 0.00% | 0.0% |
| Q1 2014 | $1,932,000 | -10.1% | 246,450 | +1.4% | 0.00% | 0.0% |
| Q4 2013 | $2,150,000 | +3.9% | 242,965 | -1.6% | 0.00% | 0.0% |
| Q3 2013 | $2,069,000 | +18.0% | 246,843 | +5.0% | 0.00% | 0.0% |
| Q2 2013 | $1,753,000 | – | 235,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,518,000 | 1.37% |
| CM Management, LLC | 600,000 | $774,000 | 0.65% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $22,059,000 | 0.43% |
| Sargent Investment Group, LLC | 414,600 | $535,000 | 0.14% |
| Ergoteles LLC | 299,005 | $386,000 | 0.02% |
| Sonora Investment Management Group, LLC | 82,000 | $106,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $55,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $138,000 | 0.01% |
| Crestline Management, LP | 66,209 | $85,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 7,845,726 | $10,121,000 | 0.01% |